Disc Medicine
Manufacturing · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
321 Arsenal St Ste 101, Watertown, Massa...Phone Number
(617) 674-9274Website
www.discmedicine.comRevenue
$19.9 MillionStock Symbol
IRONIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Disc Medicine
Disc Medicine is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. We are building a portfolio of innovative, first-in-class therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease.Explore more
Disc Medicine Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Disc Medicine your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Disc Medicine has new funding data
Website visits: Recent activity has been detected on your website
Check out if Disc Medicine is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Disc Medicine launches new products
Disc Medicine, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Disc Medicine has recently received funding, and reach out quickly before it becomes old news!
Click to see if Disc Medicine had a recent Job posting/layoffs
Earning: See what the market has to say on Disc Medicine recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Disc Medicine
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Disc Medicine
Compare insights from companies similar to Disc Medicine, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Disc Medicine is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Disc Medicine is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Disc Medicine.
Disc Medicine financials insights
Gather financial insights about Disc Medicine, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series B
$90M
2022
Unspecified
$53.5M
2023
Other Financing Round
$62.5M
Share Placement
$157.8M
2024
Debt
$200M
Disc Medicine Tech Stack
A closer look at the technologies used by Disc Medicine
Most Recent Scoops
Open Position
Event
Product Marketing, Events, Engineering, Contingent Workforce, Sales, Outsourcing, Bioengineering, Chemical Engineering, Field /Outside Sales, Field Marketing
Open Position
Open Position
Person-Based
Stake & Stock Ownership, Finance, Financial Transactions
Disc Medicine News & Media
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, July 31, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing public.Disc Medicine Reports Second Quarter 2026 Financial Results and Provides Business Update
WATERTOWN, Mass., July 30, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today reported financial results for the second quarter ended June 30, 2026, and provided a review of recent program and corporate developments.Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing public.Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
NEW YORK, July 20, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Disc Medicine
Sign Up For FreeTo access detailed company insights
Disc Medicine is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. We are building a portfolio of innovative, first-in-class therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower... Read More
